sema + cagrilintide blend CS10 (Cagrilintide 5 mg Semaglutide 5 mg) – podwójny agonista CAGRI

Results from skincare ingredients vary based on skin type, concentration, formulation, and consistency of use

The material supplied here is research-grade for in vitro laboratory study only

Quality control risk Most BPC-157 sold in the U.S

My protocol during this period: Retatrutide: 2mg weekly subcutaneous injection (ramped to 4mg by week 10) GHK-Cu: 1mg daily subcutaneous, rotated injection sites Cycle length: 12 weeks on, 4 weeks off Training: 4 days resistance training per week, 8,000 to 10,000 steps daily Protein intake: 130g daily minimum I sourced both from Red Fox Peptides

Clinically, small trials of topical GHK-Cu creams have measured significant increases in skin density and elasticity after several weeks of use